MedicarePartD.guide

A non-government resource built from CMS public data

HIV treatment and prevention on AARP Medicare Rx Preferred from UHC (S5921-403)

Biktarvy, Dovato, Descovy and the other common HIV regimens, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Texas
Premium
$114.80/month
Deductible
$130.00, doesn't apply to tier 1 and 2
Change plan

10 of 11 HIV drugs are covered on this plan. None require prior authorization.

1 isn't on the formulary (Truvada).

  • Biktarvy
    bictegravir/emtricitabine/tenofovir alafenamide
    Covered
    from $1,322.89
    Tier 5
  • Dovato
    dolutegravir and lamivudine
    Covered
    $1,018.99
    Tier 5
  • Triumeq
    abacavir/dolutegravir/lamivudine
    Covered
    from $878.89
    Tier 4
  • Genvoya
    elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide
    Covered
    $1,387.36
    Tier 5
  • Odefsey
    emtricitabine/rilpivirine/tenofovir alafenamide
    Covered
    $1,263.23
    Tier 5
  • Symtuza
    darunavir/cobicistat/emtricitabine/tenofovir alafenamide
    Covered
    $1,474.80
    Tier 5
  • Juluca
    dolutegravir and rilpivirine
    Covered
    $1,182.86
    Tier 5
  • Descovy
    emtricitabine and tenofovir alafenamide
    Covered
    from $723.27
    Tier 5
  • emtricitabine-tenofovir
    generic Truvada
    Covered
    from $7.23
    Tier 4
  • Tivicay
    dolutegravir
    Covered
    from $464.43
    Tier 5
Not on the formulary
Truvada

Patient cost for a 30-day supply at a preferred retail pharmacy, after the $130.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list